Literature DB >> 15847843

Brain arteriovenous malformations in adults.

Jae H Choi1, Jay P Mohr.   

Abstract

Arteriovenous malformations of the brain (AMB) can cause stroke when they rupture. Epidemiological and imaging research has found that about 50% of patients with AMB present with haemorrhage, and the other 50% either present with non-focal symptoms, such as headache, seizure, or focal neurological deficit, or have no symptoms and the lesion is found during unrelated investigations. Treatment for arteriovenous malformations aims to prevent and resolve haemorrhage and is a growing interdisciplinary challenge. Although treatment uses enormous resources, there have been few studies on the risk-benefit ratios for treatment of unruptured AMB and the best approaches.

Entities:  

Mesh:

Year:  2005        PMID: 15847843     DOI: 10.1016/S1474-4422(05)70073-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  41 in total

1.  Apolipoprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations.

Authors:  Ludmila Pawlikowska; K Y Trudy Poon; Achal S Achrol; Charles E McCulloch; Connie Ha; Kristen Lum; Jonathan G Zaroff; Nerissa U Ko; S Claiborne Johnston; Stephen Sidney; Douglas A Marchuk; Michael T Lawton; Pui-Yan Kwok; William L Young
Journal:  Neurosurgery       Date:  2006-05       Impact factor: 4.654

2.  Brain arteriovenous malformation diagnosis: value of time-resolved contrast-enhanced MR angiography at 3.0T compared to DSA.

Authors:  A Machet; C Portefaix; K Kadziolka; G Robin; O Lanoix; L Pierot
Journal:  Neuroradiology       Date:  2012-03-13       Impact factor: 2.804

3.  Endovascular treatment accounts for a change in brain arteriovenous malformation natural history risk.

Authors:  X Lv; Z Wu; C Jiang; Y Li; X Yang; Y Zhang; M Lv; N Zhang
Journal:  Interv Neuroradiol       Date:  2010-07-19       Impact factor: 1.610

4.  Orbital color Doppler ultrasound as noninvasive tool in the diagnosis of anterior-draining carotid-cavernous fistula.

Authors:  Massimo Venturini; Giulia Cristel; Stefania Bianchi Marzoli; Franco Simionato; Giulia Agostini; Piero Barboni; Francesco De Cobelli; Andrea Falini; Francesco Bandello; Alessandro Del Maschio
Journal:  Radiol Med       Date:  2015-12-06       Impact factor: 3.469

5.  [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage].

Authors:  S Külkens; P Ringleb; J Diedler; W Hacke; T Steiner
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

Review 6.  Management of unbled brain arteriovenous malformation study.

Authors:  J P Mohr; Shadi Yaghi
Journal:  Neurol Clin       Date:  2015-05       Impact factor: 3.806

7.  Evaluation of the degree of arteriovenous shunting in intracranial arteriovenous malformations using pseudo-continuous arterial spin labeling magnetic resonance imaging.

Authors:  Leonard Sunwoo; Chul-Ho Sohn; Jong Young Lee; Kyung Sik Yi; Tae Jin Yun; Seung Hong Choi; Young Dae Cho; Ji-Hoon Kim; Sun-Won Park; Moon Hee Han; Sun Ha Paek; Yong Hwy Kim; Jin Wook Kim; Hyun-Tai Chung; Dong Gyu Kim
Journal:  Neuroradiology       Date:  2015-04-24       Impact factor: 2.804

8.  G Protein-Coupled Receptor 124 (GPR124) Gene Polymorphisms and Risk of Brain Arteriovenous Malformation.

Authors:  Shantel Weinsheimer; Ari D Brettman; Ludmila Pawlikowska; D Christine Wu; Michael R Mancuso; Frank Kuhnert; Michael T Lawton; Stephen Sidney; Jonathan G Zaroff; Charles E McCulloch; William L Young; Calvin Kuo; Helen Kim
Journal:  Transl Stroke Res       Date:  2012-08-14       Impact factor: 6.829

9.  De novo arteriovenous malformations: case report and review of the literature.

Authors:  Amit Mahajan; Tejas C Manchandia; Grahame Gould; Ketan R Bulsara
Journal:  Neurosurg Rev       Date:  2009-09-29       Impact factor: 3.042

10.  Evidence of inflammatory cell involvement in brain arteriovenous malformations.

Authors:  Yongmei Chen; Wei Zhu; Andrew W Bollen; Michael T Lawton; Nicholas M Barbaro; Christopher F Dowd; Tomoki Hashimoto; Guo-Yuan Yang; William L Young
Journal:  Neurosurgery       Date:  2008-06       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.